Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like Five Prime Tanked on Early Peek of Lead Drug Data November 7, 2017 Qiagen Plans to Create Up to 800 Jobs at New UK Campus Post Brexit November 26, 2017 Why This Biotech Says It's Close to Curing the Type of Cancer That Killed March 16, 2017
